1256355-24-4 → HCID 59620074, compound
Reaction equation
Br[C:2]1[CH:11]=[CH:10][C:9]2[N:8]=[CH:7][C:6]3[N:12]([CH3:25])[C:13](=[O:24])[N:14]([C:15]4[C:16]([CH3:23])=[N:17][N:18]([CH:20]([CH3:22])[CH3:21])[CH:19]=4)[C:5]=3[C:4]=2[CH:3]=1.O.[CH3:27][N:28]([CH3:38])[C:29]1[CH:34]=[CH:33][C:32](B(O)O)=[CH:31][N:30]=1>>[CH3:27][N:28]([CH3:38])[C:29]1[N:30]=[CH:31][C:32]([C:2]2[CH:11]=[CH:10][C:9]3[N:8]=[CH:7][C:6]4[N:12]([CH3:25])[C:13](=[O:24])[N:14]([C:15]5[C:16]([CH3:23])=[N:17][N:18]([CH:20]([CH3:22])[CH3:21])[CH:19]=5)[C:5]=4[C:4]=3[CH:3]=2)=[CH:33][CH:34]=1Participants
3
Procedure
The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1-isopropyl-3-methyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate G, 50 mg, 0.125 mmol) and 2-(dimethylamino)pyridine-5-boronic acid hydrate (Fluorochem Ltd., Derbyshire, United Kingdom, 31 mg, 0.163 mmol) to give the title compound as a yellow solid. (HPLC: tR 2.31 min (Method A); M+H=442 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.90 (s, 1H), 8.27-8.18 (m, 2H), 8.07-7.99 (m, 1H), 7.90-7.82 (m, 1H), 7.62-7.55 (m, 1H), 7.41 (s, 1H), 6.70-6.61 (m, 1H), 4.62-4.49 (m, 1H), 3.56 (s, 3H), 3.04 (s, 6H), 1.96 (s, 3H), 1.49 (s, 6H))
Workup
- customThe title compound was synthesized in a similar manner
Sources & evidence
- ORD record
- ord-21be06652b9443c2b571527f36bb0a40
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08476294B2
Reaction notes
Loading…